Tumor molecular profiling of responders and non-responders following pembrolizumab monotherapy in chemotherapy resistant advanced cervical cancer

10.1016/j.gore.2018.01.009

Saved in:

Bibliographic Details
Main Authors:	Ngoi, NYL, Heong, V, Lee, XW, Huang, YQ, Thian, YL, Choo, BA, Lim, D, Lim, YW, Lim, SE, Ilancheran, A, Soong, R, Tan, DSP
Other Authors:	DIAGNOSTIC RADIOLOGY
Format:	Article
Published:	Elsevier BV 2021
Subjects:	Biomakers Cervical cancer Immune checkpoint inhibition Pembrolizumab
Online Access:	https://scholarbank.nus.edu.sg/handle/10635/206422
Tags:	Add Tag No Tags, Be the first to tag this record!
Institution:	National University of Singapore

id	sg-nus-scholar.10635-206422
record_format	dspace
spelling	sg-nus-scholar.10635-2064222024-04-11T05:26:12Z Tumor molecular profiling of responders and non-responders following pembrolizumab monotherapy in chemotherapy resistant advanced cervical cancer Ngoi, NYL Heong, V Lee, XW Huang, YQ Thian, YL Choo, BA Lim, D Lim, YW Lim, SE Ilancheran, A Soong, R Tan, DSP DIAGNOSTIC RADIOLOGY OBSTETRICS & GYNAECOLOGY Biomakers Cervical cancer Immune checkpoint inhibition Pembrolizumab 10.1016/j.gore.2018.01.009 Gynecologic Oncology Reports 24 1-May 2021-11-16T08:06:36Z 2021-11-16T08:06:36Z 2018-05-01 2021-11-10T15:17:05Z Article Ngoi, NYL, Heong, V, Lee, XW, Huang, YQ, Thian, YL, Choo, BA, Lim, D, Lim, YW, Lim, SE, Ilancheran, A, Soong, R, Tan, DSP (2018-05-01). Tumor molecular profiling of responders and non-responders following pembrolizumab monotherapy in chemotherapy resistant advanced cervical cancer. Gynecologic Oncology Reports 24 : 1-May. ScholarBank@NUS Repository. https://doi.org/10.1016/j.gore.2018.01.009 23525789 https://scholarbank.nus.edu.sg/handle/10635/206422 Elsevier BV Elements
institution	National University of Singapore
building	NUS Library
continent	Asia
country	Singapore Singapore
content_provider	NUS Library
collection	ScholarBank@NUS
topic	Biomakers Cervical cancer Immune checkpoint inhibition Pembrolizumab
spellingShingle	Biomakers Cervical cancer Immune checkpoint inhibition Pembrolizumab Ngoi, NYL Heong, V Lee, XW Huang, YQ Thian, YL Choo, BA Lim, D Lim, YW Lim, SE Ilancheran, A Soong, R Tan, DSP Tumor molecular profiling of responders and non-responders following pembrolizumab monotherapy in chemotherapy resistant advanced cervical cancer
description	10.1016/j.gore.2018.01.009
author2	DIAGNOSTIC RADIOLOGY
author_facet	DIAGNOSTIC RADIOLOGY Ngoi, NYL Heong, V Lee, XW Huang, YQ Thian, YL Choo, BA Lim, D Lim, YW Lim, SE Ilancheran, A Soong, R Tan, DSP
format	Article
author	Ngoi, NYL Heong, V Lee, XW Huang, YQ Thian, YL Choo, BA Lim, D Lim, YW Lim, SE Ilancheran, A Soong, R Tan, DSP
author_sort	Ngoi, NYL
title	Tumor molecular profiling of responders and non-responders following pembrolizumab monotherapy in chemotherapy resistant advanced cervical cancer
title_short	Tumor molecular profiling of responders and non-responders following pembrolizumab monotherapy in chemotherapy resistant advanced cervical cancer
title_full	Tumor molecular profiling of responders and non-responders following pembrolizumab monotherapy in chemotherapy resistant advanced cervical cancer
title_fullStr	Tumor molecular profiling of responders and non-responders following pembrolizumab monotherapy in chemotherapy resistant advanced cervical cancer
title_full_unstemmed	Tumor molecular profiling of responders and non-responders following pembrolizumab monotherapy in chemotherapy resistant advanced cervical cancer
title_sort	tumor molecular profiling of responders and non-responders following pembrolizumab monotherapy in chemotherapy resistant advanced cervical cancer
publisher	Elsevier BV
publishDate	2021
url	https://scholarbank.nus.edu.sg/handle/10635/206422
_version_	1800915078514475008

Tumor molecular profiling of responders and non-responders following pembrolizumab monotherapy in chemotherapy resistant advanced cervical cancer

Similar Items